A detailed history of Fiduciary Alliance LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Fiduciary Alliance LLC holds 13,275 shares of AVXL stock, worth $54,693. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,275
Holding current value
$54,693
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$4.55 - $6.75 $60,401 - $89,606
13,275 New
13,275 $66.6 Million
Q2 2023

Jul 18, 2023

BUY
$7.66 - $9.5 $71,046 - $88,112
9,275 New
9,275 $75.4 Million
Q4 2022

Jan 19, 2023

BUY
$7.65 - $14.43 $8,353 - $15,757
1,092 New
1,092 $10.1 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $321M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Fiduciary Alliance LLC Portfolio

Follow Fiduciary Alliance LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Alliance LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Alliance LLC with notifications on news.